Medline Inc. (MDLN)
| Market Cap | 58.46B |
| Revenue (ttm) | 28.43B |
| Net Income (ttm) | 1.16B |
| Shares Out | 1.31B |
| EPS (ttm) | 1.43 |
| PE Ratio | 31.12 |
| Forward PE | 30.30 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,020,323 |
| Open | 45.23 |
| Previous Close | 45.23 |
| Day's Range | 44.26 - 45.44 |
| 52-Week Range | 34.89 - 50.88 |
| Beta | n/a |
| Analysts | Strong Buy |
| Price Target | 50.48 (+13.44%) |
| Earnings Date | May 6, 2026 |
About MDLN
Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam g... [Read more]
Financial Performance
In 2025, Medline's revenue was $28.43 billion, an increase of 11.47% compared to the previous year's $25.51 billion. Earnings were $1.16 billion, a decrease of -3.42%.
Financial StatementsAnalyst Forecast
According to 23 analysts, the average rating for MDLN stock is "Strong Buy." The 12-month stock price target is $50.48, which is an increase of 13.44% from the latest price.
News
Medline announces first-in-healthcare AI robotics partnership with Symbotic
Continued investment in next-gen supply chain technology powers Medline's distribution capabilities NORTHFIELD, Ill., April 16, 2026 /PRNewswire/ -- Medline (Nasdaq: MDLN) announced a strategic agreem...
US FDA warns Medline over defective heart procedure syringes
The U.S. Food and Drug Administration has warned medical device maker Medline that its syringes used in heart procedures are defective and that the company has failed to fix the problem adequately.
Medline to report first quarter 2026 results on May 6, 2026
NORTHFIELD, Ill., April 08, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that it plans to report first quarter 2026 financial results on Wednesday, May 6, 2026.
Medline launches custom product fulfillment technology called Pick Pack Pro™
Investment in combined robotic, conveyor and packing technology supports the delivery of medical supplies directly to homes of health plan members NORTHFIELD, Ill., April 6, 2026 /PRNewswire/ -- Medl...
Medline recognizes manufacturing facilities with Golden Cone Safety Award
NORTHFIELD, Ill., April 3, 2026 /PRNewswire/ -- Medline (Nasdaq: MDLN), the largest provider of medical-surgical products and supply chain solutions serving all points of care, announced this week its...
Medline receives HIRC Member Choice Awards for supply chain achievement and renews Transparency Badge distinction
Awards selection is highest recognition for healthcare supply chain partnership NORTHFIELD, Ill., April 1, 2026 /PRNewswire/ -- Medline (Nasdaq: MDLN), the largest provider of medical-surgical product...
Medline's growth continues as it breaks ground on 1.2 million sq. ft distribution center in Midlothian, Texas
Groundbreaking is first operational initiative as a publicly traded company on its continued trajectory of growth NORTHFIELD, Ill., March 11, 2026 /PRNewswire/ -- Medline [Nasdaq: MDLN] announced duri...
Medline Transcript: Barclays 28th Annual Global Healthcare Conference
Strong Q4 and FY2025 results were driven by robust new customer signings, high fill rates, and technology investments. 2026 guidance projects 8%-9% organic growth and $3.5-$3.6 billion EBITDA, with tariff headwinds expected to normalize by year-end. Expansion in labs, dental, and international markets continues.
Medline Inc. announces closing of secondary offering of Class A common stock and full exercise of underwriters' option to purchase additional shares
NORTHFIELD, Ill., March 10, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (Nasdaq: MDLN) (“Medline”) announced today that it has closed its secondary offering of 86,250,000 shares of Medline Inc.'s Class A co...
Medline Awards Distribution Center of the Year and SAFE Awards
NORTHFIELD, Ill., March 9, 2026 /PRNewswire/ -- Medline (Nasdaq: MDLN), the largest provider of medical-surgical products and supply chain solutions serving all points of care, announced this week its...
Medline Inc. announces pricing of secondary offering of class A common stock
NORTHFIELD, Ill., March 04, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (Nasdaq: MDLN) (“Medline”) announced today the pricing of a previously announced secondary offering of 75,000,000 shares of Medline In...
Medline Inc. announces launch of secondary offering of Class A common stock
NORTHFIELD, Ill., March 03, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (Nasdaq: MDLN) (“Medline”) announced today that certain selling stockholders affiliated with Blackstone Inc., The Carlyle Group Inc., ...
Medline Analysts Boost Their Forecasts Following Q4 Results
Medline Inc (NASDAQ: MDLN) reported mixed results for the fourth quarter on Wednesday.
Medline Earnings Call Transcript: Q4 2025
Achieved double-digit sales growth and record new customer signings in 2025, with strong performance across all segments and a successful IPO strengthening the balance sheet. 2026 guidance calls for 8%-9% organic sales growth and stable EBITDA despite ongoing tariff headwinds.
Medline Reports Fourth Quarter and Full Year 2025 Results
NORTHFIELD, Ill., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline” or the “Company”) (Nasdaq: MDLN), the largest provider of medical-surgical (“med-surg”) products and supply chain solutions ...
Medline announces participation in the Barclays 28th Annual Global Healthcare Conference
NORTHFIELD, Ill., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that Jim Boyle, Chief Executive Officer, and Mike Drazin, Chief Financial Officer, are sched...
Medline to report fourth quarter and full year 2025 results on February 25, 2026
NORTHFIELD, Ill., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that it plans to report fourth quarter and full year 2025 financial results on Wednesday, Fe...
Medline Transcript: 44th Annual J.P. Morgan Healthcare Conference
Medline outlined its vertically integrated model, robust growth strategy, and focus on customer value at its first public conference appearance. Despite tariff headwinds, the company targets high single-digit revenue growth, $1B in new Prime Vendor signings annually, and margin recovery by 2027.
Analysts Say Medline Has The Secret Sauce For Sustained Growth
Several analysts initiated coverage on Medline Inc. (NASDAQ: MDLN) on Monday, one of the largest providers of medical-surgical products and supply chain solutions.
Analysts initiate Medline with bullish ratings after blockbuster IPO
Brokerages began coverage of Medline with largely bullish ratings on Monday, betting on supply chain strength and brand penetration, following the firm's upsized U.S. initial public offering in Decemb...
Medline Announces Participation in J.P. Morgan 2026 Healthcare Conference
NORTHFIELD, Ill., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that Jim Boyle, Chief Executive Officer, and Mike Drazin, Chief Financial Officer, are sched...
The Score: Medline, Tesla, Warner, Trump Media and More Stocks That Defined the Week
Here are some of the major companies whose stocks moved on the week's news.
Medline Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
NORTHFIELD, Ill., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Medline Inc. (Nasdaq: MDLN) (“Medline”) announced today that it has closed its upsized initial public offering of 248,439,654 shares of its Class A ...
Trump defends economy, CPI report returns, monster Medline IPO, and more in Morning Squawk
President Donald Trump defended the U.S. economy and blamed his predecessor. "I inherited a mess," he said.
Medline's IPO was the largest we've seen in over four years, says Jim Cramer
'Mad Money' host Jim Cramer breaks down Medline's IPO.